Literature DB >> 30936347

Septic pulmonary embolism caused by Pseudomonas aeruginosa after a CO2 laser surgery for rhinitis.

Toshinori Nishizawa1, Hiroaki Kanemura2, Torahiko Jinta2, Tomohide Tamura2.   

Abstract

A 26-year-old healthy patient had a fever and chest pain three days after nasal carbon dioxide (CO2) laser surgery for chronic and allergic rhinitis. In the emergency room, he was diagnosed as a right pneumothorax and managed as outpatients with oral antibiotic therapy and close follow-up. Six days later, in follow-up clinic, his presenting signs and symptoms included right chest pain, tachypnoea and elevated levels of white blood cell count and C reactive protein. He was diagnosed as septic pulmonary embolism (SPE) by the detection of multiple nodules with cavitation on chest CT. Culture of pleural fluids showed Pseudomonas aeruginosa Intravenous antibiotic treatment and drainage of the pleural effusion improved his condition. Since SPE occurred after nasal CO2 laser surgery in this case, careful attention should be paid to infectious complications of nasal CO2 laser surgery. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ear, nose and throat/otolaryngology; infectious diseases; respiratory medicine

Mesh:

Substances:

Year:  2019        PMID: 30936347      PMCID: PMC6453354          DOI: 10.1136/bcr-2018-228420

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Septic pulmonary emboli. A rare cause of bilateral pneumothorax in drug abusers.

Authors:  J M Aguado; R Arjona; P Ugarte
Journal:  Chest       Date:  1990-11       Impact factor: 9.410

2.  Spontaneous pneumothorax as a complication of septic pulmonary embolism in an intravenous drug user: a case report.

Authors:  Chau-Chyun Sheu; Jhi-Jhu Hwang; Jong-Rung Tsai; Tung-Heng Wang; Inn-Wen Chong; Ming-Shyan Huang
Journal:  Kaohsiung J Med Sci       Date:  2006-02       Impact factor: 2.744

3.  Overwhelming pneumonia in a healthy young nursing assistant.

Authors:  M D Cirigliano; M A Grippi
Journal:  Hosp Pract (Off Ed)       Date:  1994-01-15

4.  Using response to a standardized treatment to identify phenotypes for genetic studies of chronic rhinosinusitis.

Authors:  Marc-Elie Nader; Peter Abou-Jaoude; Myrna Cabaluna; Martin Desrosiers
Journal:  J Otolaryngol Head Neck Surg       Date:  2010-02

5.  Clinical and echocardiographic correlations in right heart endocarditis.

Authors:  I P Panidis; M N Kotler; G S Mintz; J Ross; J Weber
Journal:  Int J Cardiol       Date:  1984-07       Impact factor: 4.164

6.  Pneumothorax secondary to septic pulmonary emboli in tricuspid endocarditis.

Authors:  J E Corzo; F Lozano de León; J Gómez-Mateos; L López-Cortes; R Vázquez; F García-Bragado
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

7.  Pseudomonas spp. ISOLATED FROM THE ORAL CAVITY OF HEALTHCARE WORKERS FROM AN ONCOLOGY HOSPITAL IN MIDWESTERN BRAZIL.

Authors:  Ana Beatriz Mori Lima; Lara Stefânia Netto de Oliveira Leão-Vasconcelos; Dayane de Melo Costa; Larissa Oliveira Rocha Vilefort; Maria Cláudia Dantas Porfírio Borges André; Maria Alves Barbosa; Marinésia Aparecida Prado-Palos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

8.  Isolated Pulmonary Valve Endocarditis Complicated With Septic Emboli to the Lung Causing Pneumothorax, Pneumonia, and Sepsis in an Intravenous Drug Abuser.

Authors:  Deephak Swaminath; Yasir Yaqub; Roshni Narayanan; Ralph F Paone; Kenneth Nugent; Aliakbar Arvandi
Journal:  J Investig Med High Impact Case Rep       Date:  2013-11-28

9.  Associations and outcomes of septic pulmonary embolism.

Authors:  Umesh Goswami; Jorge A Brenes; Gopal V Punjabi; Michele M LeClaire; David N Williams
Journal:  Open Respir Med J       Date:  2014-07-24

10.  Pneumothorax Secondary to Septic Pulmonary Emboli in a Long-term Hemodialysis Patient with Psoas Abscess.

Authors:  Masahiro Okabe; Kenji Kasai; Takashi Yokoo
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.